TNGX
Tango Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +30.0% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +22 | 90.50M | $2.83B | +24 | −2 |
| Q1 2026 | 77 | 0 | 72.21M | $1.51B | +9 | −9 |
| Q4 2025 | 76 | 0 | 64.83M | $574.42M | +1 | −1 |
| Q3 2025 | 19 | +2 | 27.21M | $228.58M | +3 | −1 |
| Q2 2025 | 14 | 0 | 22.55M | $115.47M | +1 | −1 |
| Q1 2025 | 11 | +1 | 6.63M | $9.09M | +2 | −1 |
| Q4 2024 | 10 | 0 | 4.99M | $15.42M | +3 | −3 |
| Q3 2024 | 9 | -1 | 6.83M | $52.57M | +1 | −2 |
| Q2 2024 | 10 | — | 5.64M | $48.44M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 5.91M | Neu | $30.24M | 0.1% | New | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 5.46M | — | $27.97M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | The Vanguard Group ✦ (passiv) | 4.03M | — | $20.62M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passiv) | 4.03M | — | $20.62M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passiv) | 4.03M | — | $20.62M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 1.77M | +20.5% | $9.07M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passiv) | 1.77M | +27.9% | $9.06M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passiv) | 1.77M | +27.9% | $9.06M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Marshall Wace ✦ | 1.74M | -5.4% | $8.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 1.74M | -5.4% | $8.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 1.74M | -5.4% | $8.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passiv) | 1.38M | +20.8% | $7.08M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 224.08K | 0.0% | $1.15M | 0.0% | Held | 5 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 78.95K | -44.5% | $404,203 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 78.95K | -44.5% | $404,203 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 78.95K | -44.5% | $404,203 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 78.95K | -44.5% | $404,203 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 65.50K | -62.5% | $335,360 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 26 | Citadel Advisors ✦ | 55.06K | -48.3% | $281,933 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 38.40K | +72.6% | $197,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Two Sigma Investments ✦ | 22.22K | -58.0% | $113,756 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 5.58K | — | $28,559 | 0.0% | n/c | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Adage Capital Partners | $30.24M | 0.1% |
Ausgestiegen
| D. E. Shaw & Co. | $93,528 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 193 Inhaber, 180.17M Anteile, $3.72B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.